Fireside chat: Re-engineering development pathways for the rarest patients
19 Jan 2027
Theatre 4
Commercializing Advanced Therapies
Topic
CDMO CRO & Partnering,Clinical Development & Regulatory Strategy,Preclinical & Translational Development
Persona
Academic & Clinical Researchers,Biotech,Clinicians,Industry Associations & Foundations,Patient Advocates & Organizations,Payers,Pharma,Regulators & Policy Makers